𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Changes in phospholipase D isoform activity and expression in multidrug-resistant human cancer cells

✍ Scribed by Giusy Fiucci; Malgorzata Czarny; Yaakov Lavie; Di Zhao; Brygida Berse; J. Krzysztof Blusztajn; Mordechai Liscovitch


Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
171 KB
Volume
85
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Multidrug resistance (MDR) is a major cause of failure of cancer chemotherapy and is often associated with elevated expression of drug transporters such as P-glycoprotein (P-gp) in the cancer cells. MDR is, however, accompanied by additional biochemical changes including modifications of membrane composition and properties. We have shown that MDR is associated with a massive up-regulation of caveolin expression and an elevated surface density of caveolae. We report that phospholipase D (PLD), a constituent enzyme of caveolae and detergent-insoluble glycolipid-rich membranes (DIGs), is up-regulated in human MDR cancer cells. Lysates of HT-29-MDR human colon adenocarcinoma cells, MCF-7 AdrR human breast adenocarcinoma cells and the corresponding parental drug-sensitive cells, were fractionated on discontinuous sucrose density gradients. PLD activity was found to be enriched in low density fractions that contain DIGs and caveolar membranes, and the activity in these fractions was 4-to 6-fold higher in the MDR cells compared with the parental drug-sensitive cells. Utilizing specific antibodies to PLD1 and PLD2, the distribution of PLD isoforms along the gradient was determined and the PLD localized in DIGs and caveolar membranes has been identified as PLD2. Northern blot analysis of PLD1 and PLD2 mRNA levels has indicated that PLD2 mRNA is elevated in both HT-29-MDR and MCF-7 AdrR cells. PLD1 mRNA levels were either unchanged or reduced in the MDR cells. Finally, in vivo experiments have confirmed previous results showing that activation of PLD by phorbol esters is markedly potentiated in the MDR cells. We conclude that MDR is accompanied by an increase in PLD2 activity in DIGs and caveolar membranes.


πŸ“œ SIMILAR VOLUMES


Expression and regulation of phospholipa
✍ Terra C. Gibbs; Kathryn E. Meier πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 277 KB

Phospholipase D (PLD) is activated in mammalian cells in response to diverse stimuli that include growth factors, activators of protein kinase C, and agonists binding to G-protein-coupled receptors. Two forms of mammalian PLD, PLD1 and PLD2, have been identified. Expression of mRNA and protein for P

Genetic changes in the evolution of mult
✍ Timon P. H. Buys; Raj Chari; Eric H. L. Lee; May Zhang; Calum MacAulay; Stephen πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 819 KB

## Abstract The multidrug resistant (MDR) phenotype is often attributed to the activity of ATP‐binding cassette (ABC) transporters such as P‐glycoprotein (ABCB1). Previous work has suggested that modulation of MDR may not necessarily be a single gene trait. To identify factors that contribute to th

Lysophosphatidic acid stimulates phospho
✍ Chen Qi; Jin-Hyouk Park; Terra C. Gibbs; David W. Shirley; Cynthia D. Bradshaw; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 325 KB

Phospholipase D (PLD) is activated in mammalian cells in response to a variety of growth factors and may play a role in cell proliferation. Lysophosphatidic acid (LPA) is a bioactive metabolite potentially generated as a result of PLD activation. Two human prostate cancer cell lines, PC-3 and LNCaP,

Comparison of protein kinase C activity
✍ Alakananda Basu; Kelly M. Weixel πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 514 KB

Cellular sensitivity to cis-diamminedichloroplatinum(ll) (cDDP) can be regulated by protein kinase C (PKC) signal transduction pathway. Activators of PKC were shown to enhance the sensitivity of human ovarian carcinoma 2008 cells to cDDP. We have examined whether or not the PKC signal transduction p

Up-regulation of multidrug resistance tr
✍ Heng-Liang Lin; Tsung-Yun Liu; Wing-Yiu Lui; Chin-Wen Chi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 157 KB πŸ‘ 1 views

BACKGROUND. Berberine, one of the major constitutents of alkaloids of Coptis chinensis is frequently utilized in the treatment of inflammation and liver-related diseases. In Chinese herbal medicine, Coptis chinensis is used as a prophylactic drug to treat gastrointestinal disorders. In a previous st